多形性膠芽腫の治療の世界市場:市場規模・現状・予測(2019-2025)

【英語タイトル】Global Glioblastoma Multiforme Treatment Market Size, Status and Forecast 2019-2025

QYResearchが出版した調査資料(QYR9053593)・商品コード:QYR9053593
・発行会社(調査会社):QYResearch
・発行日:2019年8月7日(※2024年版があります。お問い合わせください)
・ページ数:99
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療・製薬・バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥585,000見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD7,800 ⇒換算¥1,170,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当資料は、多形性膠芽腫の治療のグローバル市場について調査・分析したレポートで、種類別(ベバシズマブ(アバスチン)、カルムスチン(BiCNU)、テモゾロマイド(テモダールとテモダルとテマド))、用途別(病院、診療所、その他)、主要地域別(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米)の市場規模、市場予測、関連企業情報などが含まれています。

・多形性膠芽腫の治療の世界市場規模
・主要企業別市場シェア
・多形性膠芽腫の治療の世界市場規模:種類別(ベバシズマブ(アバスチン)、カルムスチン(BiCNU)、テモゾロマイド(テモダールとテモダルとテマド))
・多形性膠芽腫の治療の世界市場規模:用途別(病院、診療所、その他)
・多形性膠芽腫の治療のアメリカ市場規模(種類別、用途別)
・多形性膠芽腫の治療のヨーロッパ市場規模(種類別、用途別)
・多形性膠芽腫の治療の中国市場規模(種類別、用途別)
・多形性膠芽腫の治療の日本市場規模(種類別、用途別)
・多形性膠芽腫の治療の東南アジア市場規模(種類別、用途別)
・多形性膠芽腫の治療のインド市場規模(種類別、用途別)
・多形性膠芽腫の治療の中南米市場規模(種類別、用途別)
・主要企業別分析(企業概要、製品動向、販売量など)
・多形性膠芽腫の治療の世界市場予測(2019年-2025年)
・多形性膠芽腫の治療の地域別市場予測(2019年-2025年)
...
【レポートの概要】

In 2018, the global Glioblastoma Multiforme Treatment market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.
This report focuses on the global Glioblastoma Multiforme Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Glioblastoma Multiforme Treatment development in United States, Europe and China.

The key players covered in this study
AbbVie, Inc
Activartis GmbH
Agenus Inc
Arog Pharmaceuticals, Inc
Bristol-Myers Squibb Company
Cavion LLC
Celldex Therapeutics Inc
Cortice Biosciences
Exelixis Inc
F. Hoffmann-La Roche Ltd.

Market segment by Type, the product can be split into
Bevacizumab (Avastin)
Carmustine (BiCNU)
Temozolomide (Temodar and Temodal and Temcad)

Market segment by Application, split into
Hospital
Clinic
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Glioblastoma Multiforme Treatment status, future forecast, growth opportunity, key market and key players.
To present the Glioblastoma Multiforme Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Glioblastoma Multiforme Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Glioblastoma Multiforme Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Bevacizumab (Avastin)
1.4.3 Carmustine (BiCNU)
1.4.4 Temozolomide (Temodar and Temodal and Temcad)
1.5 Market by Application
1.5.1 Global Glioblastoma Multiforme Treatment Market Share by Application (2014-2025)
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Glioblastoma Multiforme Treatment Market Size
2.2 Glioblastoma Multiforme Treatment Growth Trends by Regions
2.2.1 Glioblastoma Multiforme Treatment Market Size by Regions (2014-2025)
2.2.2 Glioblastoma Multiforme Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Glioblastoma Multiforme Treatment Market Size by Manufacturers
3.1.1 Global Glioblastoma Multiforme Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Glioblastoma Multiforme Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Glioblastoma Multiforme Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Glioblastoma Multiforme Treatment Key Players Head office and Area Served
3.3 Key Players Glioblastoma Multiforme Treatment Product/Solution/Service
3.4 Date of Enter into Glioblastoma Multiforme Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Glioblastoma Multiforme Treatment Market Size by Type (2014-2019)
4.2 Global Glioblastoma Multiforme Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Glioblastoma Multiforme Treatment Market Size (2014-2019)
5.2 Glioblastoma Multiforme Treatment Key Players in United States
5.3 United States Glioblastoma Multiforme Treatment Market Size by Type
5.4 United States Glioblastoma Multiforme Treatment Market Size by Application

6 Europe
6.1 Europe Glioblastoma Multiforme Treatment Market Size (2014-2019)
6.2 Glioblastoma Multiforme Treatment Key Players in Europe
6.3 Europe Glioblastoma Multiforme Treatment Market Size by Type
6.4 Europe Glioblastoma Multiforme Treatment Market Size by Application

7 China
7.1 China Glioblastoma Multiforme Treatment Market Size (2014-2019)
7.2 Glioblastoma Multiforme Treatment Key Players in China
7.3 China Glioblastoma Multiforme Treatment Market Size by Type
7.4 China Glioblastoma Multiforme Treatment Market Size by Application

8 Japan
8.1 Japan Glioblastoma Multiforme Treatment Market Size (2014-2019)
8.2 Glioblastoma Multiforme Treatment Key Players in Japan
8.3 Japan Glioblastoma Multiforme Treatment Market Size by Type
8.4 Japan Glioblastoma Multiforme Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Glioblastoma Multiforme Treatment Market Size (2014-2019)
9.2 Glioblastoma Multiforme Treatment Key Players in Southeast Asia
9.3 Southeast Asia Glioblastoma Multiforme Treatment Market Size by Type
9.4 Southeast Asia Glioblastoma Multiforme Treatment Market Size by Application

10 India
10.1 India Glioblastoma Multiforme Treatment Market Size (2014-2019)
10.2 Glioblastoma Multiforme Treatment Key Players in India
10.3 India Glioblastoma Multiforme Treatment Market Size by Type
10.4 India Glioblastoma Multiforme Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Glioblastoma Multiforme Treatment Market Size (2014-2019)
11.2 Glioblastoma Multiforme Treatment Key Players in Central & South America
11.3 Central & South America Glioblastoma Multiforme Treatment Market Size by Type
11.4 Central & South America Glioblastoma Multiforme Treatment Market Size by Application

12 International Players Profiles
12.1 AbbVie, Inc
12.1.1 AbbVie, Inc Company Details
12.1.2 Company Description and Business Overview
12.1.3 Glioblastoma Multiforme Treatment Introduction
12.1.4 AbbVie, Inc Revenue in Glioblastoma Multiforme Treatment Business (2014-2019)
12.1.5 AbbVie, Inc Recent Development
12.2 Activartis GmbH
12.2.1 Activartis GmbH Company Details
12.2.2 Company Description and Business Overview
12.2.3 Glioblastoma Multiforme Treatment Introduction
12.2.4 Activartis GmbH Revenue in Glioblastoma Multiforme Treatment Business (2014-2019)
12.2.5 Activartis GmbH Recent Development
12.3 Agenus Inc
12.3.1 Agenus Inc Company Details
12.3.2 Company Description and Business Overview
12.3.3 Glioblastoma Multiforme Treatment Introduction
12.3.4 Agenus Inc Revenue in Glioblastoma Multiforme Treatment Business (2014-2019)
12.3.5 Agenus Inc Recent Development
12.4 Arog Pharmaceuticals, Inc
12.4.1 Arog Pharmaceuticals, Inc Company Details
12.4.2 Company Description and Business Overview
12.4.3 Glioblastoma Multiforme Treatment Introduction
12.4.4 Arog Pharmaceuticals, Inc Revenue in Glioblastoma Multiforme Treatment Business (2014-2019)
12.4.5 Arog Pharmaceuticals, Inc Recent Development
12.5 Bristol-Myers Squibb Company
12.5.1 Bristol-Myers Squibb Company Company Details
12.5.2 Company Description and Business Overview
12.5.3 Glioblastoma Multiforme Treatment Introduction
12.5.4 Bristol-Myers Squibb Company Revenue in Glioblastoma Multiforme Treatment Business (2014-2019)
12.5.5 Bristol-Myers Squibb Company Recent Development
12.6 Cavion LLC
12.6.1 Cavion LLC Company Details
12.6.2 Company Description and Business Overview
12.6.3 Glioblastoma Multiforme Treatment Introduction
12.6.4 Cavion LLC Revenue in Glioblastoma Multiforme Treatment Business (2014-2019)
12.6.5 Cavion LLC Recent Development
12.7 Celldex Therapeutics Inc
12.7.1 Celldex Therapeutics Inc Company Details
12.7.2 Company Description and Business Overview
12.7.3 Glioblastoma Multiforme Treatment Introduction
12.7.4 Celldex Therapeutics Inc Revenue in Glioblastoma Multiforme Treatment Business (2014-2019)
12.7.5 Celldex Therapeutics Inc Recent Development
12.8 Cortice Biosciences
12.8.1 Cortice Biosciences Company Details
12.8.2 Company Description and Business Overview
12.8.3 Glioblastoma Multiforme Treatment Introduction
12.8.4 Cortice Biosciences Revenue in Glioblastoma Multiforme Treatment Business (2014-2019)
12.8.5 Cortice Biosciences Recent Development
12.9 Exelixis Inc
12.9.1 Exelixis Inc Company Details
12.9.2 Company Description and Business Overview
12.9.3 Glioblastoma Multiforme Treatment Introduction
12.9.4 Exelixis Inc Revenue in Glioblastoma Multiforme Treatment Business (2014-2019)
12.9.5 Exelixis Inc Recent Development
12.10 F. Hoffmann-La Roche Ltd.
12.10.1 F. Hoffmann-La Roche Ltd. Company Details
12.10.2 Company Description and Business Overview
12.10.3 Glioblastoma Multiforme Treatment Introduction
12.10.4 F. Hoffmann-La Roche Ltd. Revenue in Glioblastoma Multiforme Treatment Business (2014-2019)
12.10.5 F. Hoffmann-La Roche Ltd. Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Glioblastoma Multiforme Treatment Key Market Segments
Table Key Players Glioblastoma Multiforme Treatment Covered
Table Global Glioblastoma Multiforme Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Glioblastoma Multiforme Treatment Market Size Market Share by Type 2014-2025
Figure Bevacizumab (Avastin) Figures
Table Key Players of Bevacizumab (Avastin)
Figure Carmustine (BiCNU) Figures
Table Key Players of Carmustine (BiCNU)
Figure Temozolomide (Temodar and Temodal and Temcad) Figures
Table Key Players of Temozolomide (Temodar and Temodal and Temcad)
Table Global Glioblastoma Multiforme Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Case Studies
Figure Clinic Case Studies
Figure Others Case Studies
Figure Glioblastoma Multiforme Treatment Report Years Considered
Table Global Glioblastoma Multiforme Treatment Market Size 2014-2025 (Million US$)
Figure Global Glioblastoma Multiforme Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Glioblastoma Multiforme Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Glioblastoma Multiforme Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Glioblastoma Multiforme Treatment Market Share by Regions 2014-2019
Figure Global Glioblastoma Multiforme Treatment Market Share by Regions 2014-2019
Figure Global Glioblastoma Multiforme Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Glioblastoma Multiforme Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Glioblastoma Multiforme Treatment Market Share by Manufacturers (2014-2019)
Figure Global Glioblastoma Multiforme Treatment Market Share by Manufacturers in 2018
Table Global Glioblastoma Multiforme Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Glioblastoma Multiforme Treatment Product/Solution/Service
Table Date of Enter into Glioblastoma Multiforme Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Glioblastoma Multiforme Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Glioblastoma Multiforme Treatment Market Size Share by Type (2014-2019)
Figure Global Glioblastoma Multiforme Treatment Market Size Market Share by Type (2014-2019)
Table Global Glioblastoma Multiforme Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Glioblastoma Multiforme Treatment Market Size Share by Application (2014-2019)
Figure Global Glioblastoma Multiforme Treatment Market Size Market Share by Application (2014-2019)
Figure Global Glioblastoma Multiforme Treatment Revenue Market Share by Application in 2018
Figure United States Glioblastoma Multiforme Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Glioblastoma Multiforme Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Glioblastoma Multiforme Treatment Market Share (2018-2019)
Table United States Glioblastoma Multiforme Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Glioblastoma Multiforme Treatment Market Share by Type (2014-2019)
Table United States Glioblastoma Multiforme Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Glioblastoma Multiforme Treatment Market Share by Application (2014-2019)
Figure Europe Glioblastoma Multiforme Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Glioblastoma Multiforme Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Glioblastoma Multiforme Treatment Market Share (2018-2019)
Table Europe Glioblastoma Multiforme Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Glioblastoma Multiforme Treatment Market Share by Type (2014-2019)
Table Europe Glioblastoma Multiforme Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Glioblastoma Multiforme Treatment Market Share by Application (2014-2019)
Figure China Glioblastoma Multiforme Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Glioblastoma Multiforme Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Glioblastoma Multiforme Treatment Market Share (2018-2019)
Table China Glioblastoma Multiforme Treatment Market Size by Type (2014-20189) (Million US$)
Table China Glioblastoma Multiforme Treatment Market Share by Type (2014-2019)
Table China Glioblastoma Multiforme Treatment Market Size by Application (2014-2019) (Million US$)
Table China Glioblastoma Multiforme Treatment Market Share by Application (2014-2019)
Figure Japan Glioblastoma Multiforme Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Glioblastoma Multiforme Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Glioblastoma Multiforme Treatment Market Share (2018-2019)
Table Japan Glioblastoma Multiforme Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Glioblastoma Multiforme Treatment Market Share by Type (2014-2019)
Table Japan Glioblastoma Multiforme Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Glioblastoma Multiforme Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Glioblastoma Multiforme Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Glioblastoma Multiforme Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Glioblastoma Multiforme Treatment Market Share (2018-2019)
Table Southeast Asia Glioblastoma Multiforme Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Glioblastoma Multiforme Treatment Market Share by Type (2014-2019)
Table Southeast Asia Glioblastoma Multiforme Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Glioblastoma Multiforme Treatment Market Share by Application (2014-2019)
Figure India Glioblastoma Multiforme Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Glioblastoma Multiforme Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Glioblastoma Multiforme Treatment Market Share (2018-2019)
Table India Glioblastoma Multiforme Treatment Market Size by Type (2014-2019) (Million US$)
Table India Glioblastoma Multiforme Treatment Market Share by Type (2014-2019)
Table India Glioblastoma Multiforme Treatment Market Size by Application (2014-2019) (Million US$)
Table India Glioblastoma Multiforme Treatment Market Share by Application (2014-2019)
Figure Central & South America Glioblastoma Multiforme Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Glioblastoma Multiforme Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Glioblastoma Multiforme Treatment Market Share (2018-2019)
Table Central & South America Glioblastoma Multiforme Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Glioblastoma Multiforme Treatment Market Share by Type (2014-2019)
Table Central & South America Glioblastoma Multiforme Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Glioblastoma Multiforme Treatment Market Share by Application (2014-2019)
Table AbbVie, Inc Company Details
Table AbbVie, Inc Revenue in Glioblastoma Multiforme Treatment Business (2014-2019) (Million US$)
Figure AbbVie, Inc Revenue Growth Rate in Glioblastoma Multiforme Treatment Business (2014-2019)
Table AbbVie, Inc Recent Development
Table Activartis GmbH Company Details
Table Activartis GmbH Revenue in Glioblastoma Multiforme Treatment Business (2014-2019)(Million US$)
Figure Activartis GmbH Revenue Growth Rate in Glioblastoma Multiforme Treatment Business (2014-2019)
Table Activartis GmbH Recent Development
Table Agenus Inc Company Details
Table Agenus Inc Revenue in Glioblastoma Multiforme Treatment Business (2014-2019)(Million US$)
Figure Agenus Inc Revenue Growth Rate in Glioblastoma Multiforme Treatment Business (2014-2019)
Table Agenus Inc Recent Development
Table Arog Pharmaceuticals, Inc Company Details
Table Arog Pharmaceuticals, Inc Revenue in Glioblastoma Multiforme Treatment Business (2014-2019)(Million US$)
Figure Arog Pharmaceuticals, Inc Revenue Growth Rate in Glioblastoma Multiforme Treatment Business (2014-2019)
Table Arog Pharmaceuticals, Inc Recent Development
Table Bristol-Myers Squibb Company Company Details
Table Bristol-Myers Squibb Company Revenue in Glioblastoma Multiforme Treatment Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Company Revenue Growth Rate in Glioblastoma Multiforme Treatment Business (2014-2019)
Table Bristol-Myers Squibb Company Recent Development
Table Cavion LLC Company Details
Table Cavion LLC Revenue in Glioblastoma Multiforme Treatment Business (2014-2019)(Million US$)
Figure Cavion LLC Revenue Growth Rate in Glioblastoma Multiforme Treatment Business (2014-2019)
Table Cavion LLC Recent Development
Table Celldex Therapeutics Inc Company Details
Table Celldex Therapeutics Inc Revenue in Glioblastoma Multiforme Treatment Business (2014-2019)(Million US$)
Figure Celldex Therapeutics Inc Revenue Growth Rate in Glioblastoma Multiforme Treatment Business (2014-2019)
Table Celldex Therapeutics Inc Recent Development
Table Cortice Biosciences Company Details
Table Cortice Biosciences Revenue in Glioblastoma Multiforme Treatment Business (2014-2019)(Million US$)
Figure Cortice Biosciences Revenue Growth Rate in Glioblastoma Multiforme Treatment Business (2014-2019)
Table Cortice Biosciences Recent Development
Table Exelixis Inc Company Details
Table Exelixis Inc Revenue in Glioblastoma Multiforme Treatment Business (2014-2019)(Million US$)
Figure Exelixis Inc Revenue Growth Rate in Glioblastoma Multiforme Treatment Business (2014-2019)
Table Exelixis Inc Recent Development
Table F. Hoffmann-La Roche Ltd. Company Details
Table F. Hoffmann-La Roche Ltd. Revenue in Glioblastoma Multiforme Treatment Business (2014-2019)(Million US$)
Figure F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Glioblastoma Multiforme Treatment Business (2014-2019)
Table F. Hoffmann-La Roche Ltd. Recent Development
Table Global Glioblastoma Multiforme Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Glioblastoma Multiforme Treatment Market Size Share by Regions (2019-2025)
Figure Global Glioblastoma Multiforme Treatment Market Size Share by Regions in 2025
Figure United States Glioblastoma Multiforme Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Glioblastoma Multiforme Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Glioblastoma Multiforme Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Glioblastoma Multiforme Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Glioblastoma Multiforme Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Glioblastoma Multiforme Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Glioblastoma Multiforme Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Glioblastoma Multiforme Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Glioblastoma Multiforme Treatment Market Size by Product (2019-2025)
Figure Global Glioblastoma Multiforme Treatment Market Size by Product in 2025
Table Global Glioblastoma Multiforme Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Glioblastoma Multiforme Treatment Market Size by Application (2019-2025)
Figure Global Glioblastoma Multiforme Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


★調査レポート[多形性膠芽腫の治療の世界市場:市場規模・現状・予測(2019-2025)] (コード:QYR9053593)販売に関する免責事項を必ずご確認ください。
★調査レポート[多形性膠芽腫の治療の世界市場:市場規模・現状・予測(2019-2025)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆